International Region of Birth and Long‐Term Outcomes for Patients Undergoing Colorectal Cancer Resection in an Australian Population
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70160 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von James A Pasch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Macquarie University Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Emigrants and Immigrants. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nepean Blue Mountains Local Health District.
Abstract (Originalsprache)
Background
Overseas birth is associated with a survival advantage in colorectal cancer in Australia. We wished to analyse this survival based on global region of birth, controlling for cancer‐specific and other causes of death.
Methods
A database of resected colorectal cancers from 2010 to 2016 ( n = 1596) was grouped according to patient global region of birth. Chi‐squared testing was used to compare factors including patient demographics and AJCC stage. Kaplan–Meier and competing‐risk analysis were used to compare 5‐year survival outcomes between patients born in different regions, and regression analysis was used to control for age.
Results
751 (47.1%) patients were born overseas. 385 (24.1%) originated from Europe, 124 (7.8%) from East and SE Asia, 92 (5.8%) from the Middle East, and the remainder from other global regions. Immigrants from East or SE Asia were more likely to present with node‐positive disease ( p = 0.048) than those born in Australia. Immigrants from East and SE Asia and the Middle East had significantly better all‐cause 5‐year survival than patients born in Australia (73.4% and 80.4% vs. 60.4%, p < 0.0001). Immigrants from the Middle East retained their cancer‐specific survival advantage after competing risk analysis (HR 0.76, p = 0.027). Immigrants from Europe displayed no significant difference in all‐cause or disease‐specific survival compared to individuals born in Australia.
Conclusion
Patients born in the Middle East appear to have a colorectal cancer‐specific survival advantage compared to those born in Australia, unrelated to stage at presentation. This has significant implications for prognosis and future research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Macquarie University Hospital, Sydney, New South Wales, Australia.
- University of Sydney, Sydney, New South Wales, Australia.
- Sydney Adventist Hospital, Sydney, New South Wales, Australia.
- Westmead Hospital, Sydney, New South Wales, Australia.
- John Hunter Hospital, Newcastle, New South Wales, Australia.
- Nepean Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: James A Pasch, Kar Yin Fok, David Goltsman, Ewan MacDermid
Förderung
- Nepean Blue Mountains Local Health District
Zitieren
APA
Pasch, J. A., Fok, K. Y., Goltsman, D., Premaratne, C., & MacDermid, E. (2025). International Region of Birth and Long‐Term Outcomes for Patients Undergoing Colorectal Cancer Resection in an Australian Population. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70160
Vancouver
Pasch JA, Fok KY, Goltsman D, Premaratne C, MacDermid E. International Region of Birth and Long‐Term Outcomes for Patients Undergoing Colorectal Cancer Resection in an Australian Population. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70160
BibTeX
@article{Pasch2025,
author = {Pasch, James A and Fok, Kar Yin and Goltsman, David and Premaratne, Chatika and MacDermid, Ewan},
title = {International Region of Birth and Long‐Term Outcomes for Patients Undergoing Colorectal Cancer Resection in an Australian Population},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70160}
}
EUVIMED